| Description | Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits its antitumor activity by blocking CD47 and binds primarily to the N-terminal pyroglutamate of CD47, and can be used in combination with other compounds for the treatment of recurrent myeloma. |
| Synonyms | Hu5F9-G4, Magrolimab (anti-CD47) |
| molecular weight | N/A |
| CAS | 2169232-81-7 |
| Storage | store at low temperature | store at -20°C |
| References | 1. Saygin C, et al. Current and emerging strategies for management of myelodysplastic syndromes. Blood Rev. 2021 Jul;48:100791. |